Director
University of North Texas Health Science Center
Disclosure(s): TenNor Therapeutics (Suzhou) Ltd: Investigator
Before leading the PreClinical Research Services group, Bill was Director of Drug Evaluation at Cumbre Pharmaceuticals Inc. where he was responsible for animal efficacy models, pharmacology and all pre-clinical research and development efforts through IND submission focused on the discovery & development of new antimicrobial agents. Prior to this, he was a Group Leader in Infectious Disease Discovery Research at Wyeth Research (Pfizer), Lederle Laboratories and Schering-Plough (Merck), holding various positions of responsibility in antibacterial, antiviral and antifungal drug discovery research for over 40 years. His responsibilities included leading in vitro and in vivo evaluation of novel test articles from medicinal synthetic and natural products chemistry. He has worked on numerous antibacterial programs including the development of the marketed antibiotics; Suprax, Zosyn and Tygacil. His expertise encompasses the development of animal research models, evaluation of new and novel therapeutic agents as well as pharmacokinetic / pharmacodynamic analysis. He has authored / co-authored over 100 research presentations and journal articles.